Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C29H38O7 |
| Molecular Weight | 498.6078 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 8 / 8 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)=CC(=O)O[C@H]1CC[C@]2(C=O)[C@H]3CC[C@]4(C)[C@H](CC[C@]4(O)[C@@H]3CC[C@]2(O)C1)C5=COC(=O)C=C5
InChI
InChIKey=RIOSSPWEPWYRLD-SBQWKNPYSA-N
InChI=1S/C29H38O7/c1-18(2)14-25(32)36-20-6-11-27(17-30)22-7-10-26(3)21(19-4-5-24(31)35-16-19)9-13-29(26,34)23(22)8-12-28(27,33)15-20/h4-5,14,16-17,20-23,33-34H,6-13,15H2,1-3H3/t20-,21+,22-,23+,26+,27-,28-,29-/m0/s1
Acrihellin (D 12316) is a cardiotonic drug. It is characterized as a cardiosteroid. In isolated organ (Langendorff heart) the positive inotropic effect proved to be stronger in comparison to digoxin. Also in dogs and cats acrihellin increases the contractile force of the myocardium; especially in failing canine heart, it increases the force of contraction (strain-gauge) and velocity of pressure rise (dp/dt max). In classical glycoside test on cat (Hatcher's dose) acrihellin is more effective than digoxin and methyldigoxin on weight basis, equivalent on a molar basis. The therapeutical index of acrihellin is like that of methyldigoxin. In cats and dogs, the compound is absorbed rapidly and almost completely, especially when administered intraduodenally.
Originator
Approval Year
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6685487
There was a slight acceleration of spontaneous frequency of guinea pig sino-atrial preparations after administering rather high doses (10(-6) mol/l) of Acrihellin.
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C78322
Created by
admin on Mon Mar 31 18:10:58 GMT 2025 , Edited by admin on Mon Mar 31 18:10:58 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL2106642
Created by
admin on Mon Mar 31 18:10:58 GMT 2025 , Edited by admin on Mon Mar 31 18:10:58 GMT 2025
|
PRIMARY | |||
|
6917708
Created by
admin on Mon Mar 31 18:10:58 GMT 2025 , Edited by admin on Mon Mar 31 18:10:58 GMT 2025
|
PRIMARY | |||
|
PC0M1D2T2Y
Created by
admin on Mon Mar 31 18:10:58 GMT 2025 , Edited by admin on Mon Mar 31 18:10:58 GMT 2025
|
PRIMARY | |||
|
266-909-1
Created by
admin on Mon Mar 31 18:10:58 GMT 2025 , Edited by admin on Mon Mar 31 18:10:58 GMT 2025
|
PRIMARY | |||
|
100000087672
Created by
admin on Mon Mar 31 18:10:58 GMT 2025 , Edited by admin on Mon Mar 31 18:10:58 GMT 2025
|
PRIMARY | |||
|
4819
Created by
admin on Mon Mar 31 18:10:58 GMT 2025 , Edited by admin on Mon Mar 31 18:10:58 GMT 2025
|
PRIMARY | |||
|
DTXSID601024411
Created by
admin on Mon Mar 31 18:10:58 GMT 2025 , Edited by admin on Mon Mar 31 18:10:58 GMT 2025
|
PRIMARY | |||
|
67696-82-6
Created by
admin on Mon Mar 31 18:10:58 GMT 2025 , Edited by admin on Mon Mar 31 18:10:58 GMT 2025
|
PRIMARY | |||
|
C83518
Created by
admin on Mon Mar 31 18:10:58 GMT 2025 , Edited by admin on Mon Mar 31 18:10:58 GMT 2025
|
PRIMARY | |||
|
C039328
Created by
admin on Mon Mar 31 18:10:58 GMT 2025 , Edited by admin on Mon Mar 31 18:10:58 GMT 2025
|
PRIMARY | |||
|
SUB05250MIG
Created by
admin on Mon Mar 31 18:10:58 GMT 2025 , Edited by admin on Mon Mar 31 18:10:58 GMT 2025
|
PRIMARY |
ACTIVE MOIETY